Al Faisaliah Group holds significant, active stakes in leading businesses across Saudi Arabia. With a combined workforce of over 6,000 employees across our portfolio companies, we partner closely with our portfolio companies, providing strategic direction, operational support and governance, to drive sustainable growth and market leadership.
Founded by Al Faisaliah Group in 2003, Alfa Co. was established to lead the Group’s entry into the food service sector.
Today, Alfa Co. is one of the region’s largest and most respected operators in the casual and fast-casual dining space. With 9 distinct brands operating across 10 cities in Saudi Arabia, the company owns and manages its own food warehouse and distribution network, ensuring quality and consistency at every stage.
Steak House
Award-winning American-style dining
Piatto
Authentic Italian cuisine
Fire Grill
Fresh Mexican fare
City Fresh Kitchen
Healthy grab-and-go meals
Curry Club
Cloud-based Indian concept
Burgers Steak House
Flame-grilled classics
Uncle Moe’s
Slow-smoked Southern comfort
Earth Bowls
Globally inspired bowls for healthy eating
Wings & Things
Bold-flavored wings
Driven by continuous investment in innovation, guest experience, and geographic expansion, Alfa Co. is redefining the region’s dining landscape — one meal at a time.
Established by Al Faisaliah Group in 1978, Al Safi Dairy set a global benchmark by developing the world’s largest integrated dairy farm, as recognized by the Guinness World Records.
In 2002, Al Faisaliah formed a strategic joint venture with the global dairy leader Danone Group, creating AlSafi Danone. This partnership brought together Danone’s innovation expertise and Al Faisaliah’s deep regional insight — delivering fresh, high-quality products tailored to Middle Eastern consumers. Today, AlSafi Danone is one of Saudi Arabia’s top dairy brands, supplying products to over 32,000 retailers across 12 countries. Its portfolio includes beloved household names such as:
Al Safi
Actimel
Activia
Dunkin
Alpro
With a strong legacy and a commitment to innovation, AlSafi Danone continues to shape the region’s health and nutrition landscape.
Founded in 1971, Modern Electronics Company (MEC) marked Al Faisaliah Group’s first international partnership — distributing Sony products across Saudi Arabia and supporting the Kingdom’s early media infrastructure with transistor radios,
Tape recorders, and televisions. Over the decades, MEC has grown into one of the Group’s largest and most dynamic businesses. Its enduring partnership with Sony continues to thrive, particularly in high-demand segments like PlayStation and consumer electronics. Today, MEC’s portfolio is more diversified than ever — offering home appliances, technology solutions, and services through partnerships with global brands such as Hitachi and Bissell. The company serves government, corporate, and retail customers across both physical and digital channels, delivering trusted innovation to homes and institutions throughout the region.
Driven by continuous investment in innovation, guest experience, and geographic expansion, Alfa Co. is redefining the region’s dining landscape — one meal at a time.
Leading integrated healthcare solutions provider delivering medical consumables,
Equipments and turnkey projects across the Kingdom. The JV with Philips Healthcare and partnerships with leading brands positions Tibbiyah as the go to partner for Hospitals.
Since 1973, Al Faisaliah Group has played a pioneering role in supplying advanced medical equipment and solutions to Saudi Arabia’s growing healthcare sector.
In 2013, the Group consolidated its healthcare subsidiaries under Tibbiyah, creating a focused platform for innovation, scale, and service excellence. Today, Tibbiyah is a market leader in medical equipment and consumables, built on:
Strategic Partnerships
Including a joint venture with Philips Healthcare and exclusive agreements with global leaders such as Cardinal, Steris, Nipro, Coloplast, BD, and Smith & Nephew.
Efficient Distribution
powered by Al Faisaliah’s logistics expertise, enabling real-time delivery of essential products to healthcare providers nationwide.
In February 2022, Tibbiyah was successfully listed on the NOMU (Parallel Market) with a 10x oversubscribed IPO, reaching a valuation of SAR 1.6 billion. Al Faisaliah Group retains a 75% stake, reaffirming its long-term commitment to advancing healthcare in the Kingdom.
Axantia, is a regional leader in the manufacturing, marketing, and distribution of high-quality generic pharmaceuticals.
The company operates strategically positioned manufacturing facilities in Saudi Arabia and Jordan, serving markets across the Middle East and North Africa. With the support and long-term vision of Al Faisaliah Group, Axantia has pursued a clear and focused growth strategy centered on:
Expanding its product portfolio to meet the evolving needs of healthcare systems and patients across the region.
Entering new regional markets, now reaching consumers in over 20 countries.
Investing in R&D, regulatory excellence, and operational efficiency to ensure global standards of quality, safety, and affordability.
Axantia continues to play a vital role in enhancing healthcare accessibility across the region — delivering trusted, cost-effective medications and contributing to national goals in health resilience and self-sufficiency.
Oncoclínicas&Co is Latin America’s leading oncology group and a global pioneer in precision medicine, clinical research, and integrated cancer care.
In 2024, Oncoclínicas&Co and Al Faisaliah Group formed a joint venture to launch Oncoclinics in Saudi Arabia—bringing world-class expertise and a patient-centered approach to oncology into the Kingdom. This partnership combines Oncoclínicas&Co’s cutting-edge treatments and clinical excellence with Al Faisaliah Group’s deep experience in healthcare investment and operations in Saudi Arabia. Oncoclinics is setting a new benchmark for cancer care by introducing the Kingdom’s first hub-and-spoke model of specialized outpatient oncology centers—starting in Riyadh. This network delivers advanced diagnostics, digital health integration, and coordinated multidisciplinary care, ensuring patients receive timely, effective treatment close to home.
With a mission to reduce wait times, improve outcomes, and provide comprehensive, compassionate care, Oncoclinics is poised to transform the future of oncology in Saudi Arabia.
Explore Our Latest Strategic and Capital Investments